Medicem Inc.

What Medicem Inc. does

Medicem Inc. is a privately held medical device company headquartered in Boston, Massachusetts, that develops non-pharmacologic obstetrics and gynecology devices focused on cervical ripening and women's health. The company's sole commercial product, Dilapan-S®, is an FDA-cleared mechanical cervical dilator composed of Aquacryl®, a patented proprietary synthetic hydrogel that absorbs moisture from cervical tissue and expands to exert controlled radial pressure. The device is supplied in three rod dimensions (3mm x 55mm, 4mm x 55mm, and 4mm x 65mm), packaged in boxes of 25 rods, and is indicated for cervical ripening prior to labor induction and gynecological procedural preparation. Medicem supports adoption with a Clinical Specialist field force providing implementation assistance, an Implementation Toolkit with editable protocol templates, peer discussion video content, and dedicated HEOR (health economics and outcomes research) materials covering both inpatient and outpatient care pathways, alongside compliance under California Health and Safety Code §119402 and the AdvaMed Code of Ethics.

The company's go-to-market is enterprise field sales targeting hospitals, labor and delivery units, and OB/GYN healthcare professionals, with a horizontal segmentation approach. In the United States, Dilapan-S® is distributed exclusively through authorized distributor HPSRx, with ordering available online, by phone, fax, or email. Globally, the product is commercially available in over 40 countries via a separate international site at dilapan.com. Medicem generates revenue through unit-based hardware sales of the dilator rods under a pay-as-you-go billing model; pricing is quote-based through HPSRx and not publicly disclosed. Target customers include obstetricians, maternal-fetal medicine specialists, midwives, and labor and delivery departments seeking a non-pharmacologic alternative to synthetic prostaglandins, with secondary relevance to payers and hospital administrators focused on reducing resource utilization and cesarean delivery rates.

Underlying evidence includes clinical study outcomes reported across multiple trials (e.g., 93% cervical ripening success in Gupta 2018 N=444; 87% in Saad 2019 N=208; 70–81% vaginal delivery rates across three studies; no uterine tachysystole cases in 640 women), supporting positioning against pharmacologic alternatives. The company is registered as a Massachusetts corporation, operates a Comprehensive Compliance Program, and reports an employee count in the 11–50 range, with no disclosed funding rounds, parent company, or acquisition history in the input data.

Name

Medicem Inc.

Legal name

Medicem Inc.

Website

https://dilapans.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Medicem Inc. is a Boston-based private medical device company that develops Dilapan-S, an FDA-cleared mechanical cervical dilator made from proprietary Aquacryl hydrogel for non-pharmacologic cervical ripening during labor induction, sold to hospitals and OB/GYN providers in 40+ countries.

Ownership category

akta.pro rank

Product category

Obstetric Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Minimally Invasive Gynecologic Surgery (Laparoscopy/Hysteroscopy) (HLAKAJAF)

Keywords

• Cervical ripening devices
• Obstetric medical devices
• Mechanical cervical dilators
• Labor induction products
• Women's health devices

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Medical Device Sales: Medicem generates revenue through the sale of Dilapan-S® cervical dilators to hospitals, clinical facilities, and healthcare providers. The product is sold in boxes of 25 rods with three SKU configurations (3mm x 55mm, 4mm x 55mm, 4mm x 65mm) through direct ordering via HPSRx distribution channel.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Core offering

Medicem develops and sells Dilapan-S, an FDA-cleared mechanical cervical dilator made of its proprietary Aquacryl hydrogel, used for non-pharmacologic cervical ripening prior to labor induction and gynecological procedures. The product is sold in boxes of 25 rods across three size configurations to hospitals, birthing centers, and OB/GYN providers, primarily through authorized distributor HPSRx and supported by clinical specialist field teams.

Product overview

Medicem Inc. offers a single core medical device product, Dilapan-S, a mechanical cervical dilator for cervical ripening during labor induction. The product is made from Aquacryl synthetic hydrogel and works through multiple modes of action: biophysical (moisture absorption), mechanical (radial pressure), and physiological (prostaglandin release). No platform modules, add-ons, or related product lines are offered.

Differentiator

Problem solved

Functional benefit

Products and services

• Dilapan-S

Quantifiable outcome

• 93% cervical ripening success (Gupta 2018, N=444) and 87% success (Saad 2019, N=208) without additional ripening needed
• +7 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• HPSRxcoreChannel Partner/ Reseller/ DistributorHPSRx is the authorized distributor for Dilapan-S® in the United States. Healthcare providers order through HPSRx's online platform, phone, fax, or email. The distributor handles product fulfillment and customer service for ordering inquiries.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Becton Dickinson (BD): BD is a broad medical device and consumables incumbent with deep hospital distribution relationships. Their women's health and OB product lines make them comparable on distribution and hospital sales motion, even though they don't compete head-on in mechanical cervical ripening.
• Hologic: Hologic is a large women's health medical device company spanning diagnostics, surgical, and OB/GYN. While not a direct cervical ripening competitor, they are the dominant incumbent in women's health hospital sales channels and a likely strategic acquirer of niche OB/GYN assets.
• Medtronic: Medtronic is a broad medical device incumbent with hospital sales infrastructure spanning many specialties. Their hospital relationships and field force make them a relevant comparable for sales motion, though they do not specialize in cervical ripening.
• Teleflex: Teleflex is a specialty medical device company with a portfolio spanning OB, surgical, and anesthesia. They have established hospital sales channels into L&D and a comparable specialty medical device commercial model.
• CONMED: CONMED is a mid-sized medical device company serving surgical and specialty procedural markets including OB/GYN. Comparable as a specialty medical device company with hospital-focused sales and similar GTM motion to Medicem.

Direct peers

• Cook Medical: Cook Medical manufactures the Cook Cervical Ripening Balloon and Atad Ripener, which are direct mechanical alternatives to Dilapan-S for cervical ripening during labor induction. They are the closest direct competitor in the mechanical cervical dilator category.
• Laborie Medical Technologies: Laborie (which acquired Clinical Innovations) sells obstetric products including the Koala Intrauterine Pressure Catheter and other L&D consumables. They directly serve the same hospital labor and delivery units that Medicem targets with Dilapan-S.
• CooperSurgical: CooperSurgical is a women's health medical device company with a broad OB/GYN portfolio including instruments and consumables used in labor and delivery. Comparable as a women's health specialty medical device company selling to OB/GYN providers and hospitals.

Emerging players

• Minerva Surgical: Minerva Surgical is a women's health medical device company focused on gynecological procedures. While focused on a different OB/GYN subspecialty, they are comparable as a small-cap, single-therapeutic-area women's health device company with similar commercial dynamics.
• Ferring Pharmaceuticals: Ferring manufactures Propess (dinoprostone vaginal insert), a leading pharmacologic cervical ripening product. While not a medical device company, they are a key competitor in the cervical ripening therapeutic area and serve the same OB/GYN prescribing decision-maker.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/medicem-inc

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medicem Inc.